Form 4: CEO Robert Ball Exercises Options in Shoulder Innovations
Statement of Changes in Beneficial Ownership
CEO and Executive Chairman Robert Ball exercised 10,000 stock options in Shoulder Innovations, Inc. on April 30, 2026.
Summary
- Robert Ball, CEO and Executive Chairman of Shoulder Innovations, Inc., exercised 10,000 stock options at an exercise price of $2.48 per share.
- Following the transaction, Ball's direct beneficial ownership of common stock increased to 300,018 shares.
- The filing also notes the receipt of 11,152 shares via in-kind distributions from investment funds, which were previously omitted from direct ownership reporting.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, as it represents a routine exercise of vested equity compensation by an executive.
Positives
- Insider confidence demonstrated through the exercise of stock options.
- Increase in direct equity stake held by the CEO and Executive Chairman.
Negatives
- None identified in this transaction filing.
Risks
- Market volatility affecting the value of equity holdings.
- Reliance on the continued performance of the company's common stock.
Future Outlook
No forward-looking guidance provided in this regulatory filing.
Industry Context
StockSavvy.ai notes that insider option exercises are standard corporate governance events that typically reflect executive compensation cycles rather than shifts in strategic outlook.
Comparison to Industry Standards
- The transaction aligns with standard executive equity compensation practices observed in the medical device sector.
- The reporting of in-kind distributions from investment funds is consistent with standard SEC disclosure requirements for beneficial ownership.
Related Party Transactions
- Receipt of 4,400 shares from Cultivate MD Capital Fund I, LLC and 6,752 shares from Genesis Investment Holdings.
Stakeholder Impact
- Increased alignment between the CEO and shareholders through higher direct equity ownership.
Next Steps
- Continued vesting of remaining derivative securities as per the established schedule.
Key Dates
| Date | Description |
|---|---|
| 05/17/2024 | Initial vesting date for the exercised stock options. |
| 04/30/2026 | Date of the option exercise transaction and filing date. |
| 05/17/2033 | Expiration date of the stock options. |
Keywords
Shoulder Innovations, SI, Form 4, Insider Trading, Stock Options, Executive Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.